<DOC>
	<DOCNO>NCT00822536</DOCNO>
	<brief_summary>To compare treatment aspirin alone versus combined antiplatelet treatment aspirin clopidogrel 12 month combine antiplatelet treatment follow drug-eluting stent ( DES ) implantation .</brief_summary>
	<brief_title>Optimal Duration Dual Antiplatelet Therapy After Drug-eluting Stent Implantation</brief_title>
	<detailed_description>Drug-eluting stent ( DES ) substantially reduce restenosis compare bare metal stent represent significant advance percutaneous coronary intervention ( PCIs ) . Accordingly , DES rapidly adopt practice currently use majority PCI procedure . Despite rapid acceptance , DES without limitation . In particular , patient receive DES ( like receive conventional bare metal stent ) remain risk 1 % 2 % incidence stent thrombosis , often associate devastating consequence like death myocardial infarction . Understanding eliminate mediator stent thrombosis thus important goal optimize clinical benefit DES . Delayed endothelial coverage DES implantation demonstrate think prolong window vulnerability stent thrombosis . Consequently , current recommendation DES : dual antiplatelet therapy least 12 month patient low risk bleeding , especially `` off-label `` use . Because rare severe late stent thrombosis , dual antiplatelet therapy prescribe clinical practice several years.But clearly demonstrate combination aspirin clopidogrel ( thienopyridine use ) significantly increase rate severe moderate bleeding compare aspirin alone . This important consider possibility necessity prolong combined antiplatelet therapy stent implantation.ProposalTo compare treatment aspirin alone versus combined antiplatelet treatment aspirin clopidogrel 12 month combine antiplatelet treatment DES implantation NB : On decision sponsor , late patient monitoring advance September 30 , 2014 instead January 2015 .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Inclusion do either stenting 12 month later : A : Patients admit DES implantation select . After 12 month bi therapy , randomize B : patient get DES implantation 12 month select randomised Inclusion criterion : Patients aspirin clopidogrel therapy 12 month DES implantation Informed , write consent patient Exclusion criterion : DES leave main coronary artery Oral anticoagulation therapy coumadin derivative Active bleeding ; bleed diathesis ; history intracranial bleeding Known allergy intolerance study medication : aspirin clopidogrel Pregnancy ( present , suspected plan ) positive pregnancy test ( In woman childbearing potential negative pregnancy test mandatory ) Patient 's inability fully comply study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Drug-eluting stent</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Stent thrombosis</keyword>
	<keyword>Myocardial infarction</keyword>
</DOC>